IQV

IQVIA Holdings Inc.

HealthcareMedical - Diagnostics & ResearchUSUSDPeers →

$181.46

LiveJun 12, 2026

Market cap

$30.29B

52w range

153.01 – 247.05

P / E

—

EPS · FY 2025

$7.84

Volume

1.08M

Revenue · FY 2025

$16.31B

+5.87% YoY

Explain this page

Arphra AIPlain-English read on IQVIA Holdings Inc.’s valuation

Revenue · 5Y

$16.31B+5.9%

FY21FY22FY23FY24FY25

Net income · 5Y

$1.36B-0.9%

FY21FY22FY23FY24FY25

Margins · FY2025

Gross margin26.3%

Operating margin14.0%

Net margin8.3%

FCF margin12.6%

income_statement_annual

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	YoY
Revenue	16.31B	15.40B	14.98B	14.41B	13.87B	+5.9%
Gross profit	4.29B	5.38B	5.24B	5.03B	4.64B	-20.3%
R&D	0	0	0	0	0	—
Operating income	2.29B	2.20B	1.98B	1.80B	1.39B	+3.9%
Net income	1.36B	1.37B	1.36B	1.09B	966.0M	-0.9%
Diluted EPS	7.84	7.49	7.29	5.72	4.95	+4.7%
Net margin	8.3%	8.9%	9.1%	7.6%	7.0%	—

Pro

Full income statement, balance sheet, and cash-flow history is included with Pro.